Dr Reddys Laboratories (RDY) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 530.13 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 991.81 Mn | 701.69 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 412.12 Mn | 370.87 Mn | 17.15 Mn | 4.64 Mn |
| 10 | RedHill Biopharma | 182.76 Mn | 182.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 304.42 Mn |
| Mar 31, 2026 | 303.69 Mn |
| Dec 31, 2025 | 302.27 Mn |
| Sep 30, 2025 | 7.97 Mn |
| Jun 30, 2025 | 299.68 Mn |
| Mar 31, 2025 | 277.79 Mn |
| Dec 31, 2024 | 285.63 Mn |
| Sep 30, 2024 | 274.69 Mn |
| Jun 30, 2024 | 272.01 Mn |
| Mar 31, 2024 | 246.56 Mn |
| Dec 31, 2023 | 242.94 Mn |
| Sep 30, 2023 | 227.36 Mn |
| Jun 30, 2023 | 226.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | 219.00 Mn |
| Sep 30, 2022 | 219.00 Mn |
| Jun 30, 2022 | 200.92 Mn |
| Mar 31, 2022 | 208.45 Mn |
| Dec 31, 2021 | 207.00 Mn |
| Sep 30, 2021 | 203.00 Mn |